Brooks Laboratories Limited (NSE:BROOKS)
India · Delayed Price · Currency is INR 58.78
-0.88 (-1.48%)
Oct 7, 2026, 3:28 PM IST
Brooks Laboratories Market Cap
Brooks Laboratories has a market cap or net worth of 1.73 billion as of October 7, 2026. That makes Brooks Laboratories the world's 37,968th most valuable company and 2,831st in India. Its market cap has decreased by 55.06% in one year.
Market Cap
1.73B
Enterprise Value
1.75B
Revenue
831.87M
Global Rank
Country Rank
#2,831 India
PE Ratio
13.28
ChartMarket Cap Chart
Since September 5, 2011, Brooks Laboratories's market cap has increased from 105.21M to 1.73B, an increase of 1,545.73%. That is a compound annual growth rate of 20.38%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 7, 2026 | 1.73B | -26.65% |
| Dec 31, 2025 | 2.36B | -50.07% |
| Dec 31, 2024 | 4.73B | 25.45% |
| Dec 29, 2023 | 3.77B | 39.59% |
| Dec 30, 2022 | 2.70B | 8.92% |
| Dec 31, 2021 | 2.48B | 51.02% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Sigachi Industries | 10.97B |
| Bafna Pharmaceuticals | 9.14B |
| Amanta Healthcare | 7.76B |
| Valiant Laboratories | 6.77B |
| Nectar Lifesciences | 2.04B |
| Par Drugs and Chemicals | 1.55B |
| Balaxi Pharmaceuticals | 1.26B |
| Alpa Laboratories | 1.24B |